Stem cells to treat muscular dystrophies - where are we?
- PMID: 21055938
- DOI: 10.1016/j.nmd.2010.10.004
Stem cells to treat muscular dystrophies - where are we?
Abstract
The muscular dystrophies are inherited disorders characterised by progressive muscle wasting and weakness. Stem cell therapy is considered to be one of the most promising strategies for treating muscular dystrophies. In this review, we first examine the evidence that a stem cell could be used to treat muscular dystrophies, and then discuss the criteria that an ideal stem cell should meet. We also highlight the importance of standard operation procedures to be followed for ensuring the consistent and reproducible efficacy of a particular stem cell. While at the moment the scientific community is looking for an ideal stem cell to treat muscular dystrophies, it is clear that in order for this field to benefit from therapeutic stem cell applications, additional careful investigations are required.
Copyright © 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Stem cells to treat muscular dystrophies.Acta Myol. 2005 Dec;24(3):181-3. Acta Myol. 2005. PMID: 16629051 Review.
-
Stem cell therapy for muscular dystrophy.Expert Opin Biol Ther. 2004 Jan;4(1):1-9. doi: 10.1517/14712598.4.1.1. Expert Opin Biol Ther. 2004. PMID: 14680464 Review.
-
Stem cell therapies to treat muscular dystrophy: progress to date.BioDrugs. 2010 Aug 1;24(4):237-47. doi: 10.2165/11534300-000000000-00000. BioDrugs. 2010. PMID: 20623990 Review.
-
The potential of stem cells in orthopaedic surgery.J Bone Joint Surg Br. 2006 Jul;88(7):841-51. doi: 10.1302/0301-620X.88B7.17305. J Bone Joint Surg Br. 2006. PMID: 16798982 Review. No abstract available.
-
Stem cell based therapies to treat muscular dystrophy.Biochim Biophys Acta. 2007 Feb;1772(2):272-83. doi: 10.1016/j.bbadis.2006.08.011. Epub 2006 Sep 6. Biochim Biophys Acta. 2007. PMID: 17034994 Review.
Cited by
-
Murine and human myogenic cells identified by elevated aldehyde dehydrogenase activity: implications for muscle regeneration and repair.PLoS One. 2011;6(12):e29226. doi: 10.1371/journal.pone.0029226. Epub 2011 Dec 15. PLoS One. 2011. PMID: 22195027 Free PMC article.
-
Autologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study.Stem Cells Int. 2013;2013:623875. doi: 10.1155/2013/623875. Epub 2013 Aug 25. Stem Cells Int. 2013. PMID: 24062774 Free PMC article.
-
Muscle Stem/Progenitor Cells and Mesenchymal Stem Cells of Bone Marrow Origin for Skeletal Muscle Regeneration in Muscular Dystrophies.Arch Immunol Ther Exp (Warsz). 2018 Oct;66(5):341-354. doi: 10.1007/s00005-018-0509-7. Epub 2018 Mar 13. Arch Immunol Ther Exp (Warsz). 2018. PMID: 29536116 Free PMC article. Review.
-
Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy.Stem Cells Transl Med. 2021 Oct;10(10):1406-1418. doi: 10.1002/sctm.21-0054. Epub 2021 Jul 22. Stem Cells Transl Med. 2021. PMID: 34291884 Free PMC article.
-
The Rag2⁻Il2rb⁻Dmd⁻ mouse: a novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies.Mol Ther. 2013 Oct;21(10):1950-7. doi: 10.1038/mt.2013.186. Epub 2013 Aug 23. Mol Ther. 2013. PMID: 23975040 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical